Gsk Plc ADR (GSK)
38.06 x 11 38.25 x 1
Post-market by (Cboe BZX)
38.06 +0.63 (+1.68%) 04/28/25 [NYSE]
38.06 x 11 38.25 x 1
Post-market 38.16 +0.10 (+0.26%) 17:08 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | GSK | BMY | REGN | ||
| Company | Gsk Plc ADR | Bristol-Myers Squibb Company | Regeneron Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | ||
| Open | 37.78 | 48.31 | 603.36 | ||
| High | 38.20 | 48.86 | 614.83 | ||
| Low | 37.77 | 47.92 | 601.19 | ||
| Last | 38.06 | 48.46 | 610.86 | ||
| Change | +0.63 | +0.56 | +8.22 | ||
| % Change | +1.68% | +1.17% | +1.36% | ||
| Volume | 5,758,800 | 18,574,600 | 1,175,200 | ||
| 20-Day Average Volume | 6,373,260 | 15,737,605 | 1,119,560 | ||
| Previous Close | 37.43 | 47.90 | 602.64 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 36.34 | 52.44 | 582.86 | ||
| 20-Day Raw Stochastic | 83.59% | 10.40% | 73.64% | ||
| 20-Day Relative Strength | 55.31% | 32.58% | 48.46% | ||
| Weighted Alpha | -8.55 | +1.35 | -40.32 | ||
| Today's Opinion | 24% Buy | 56% Sell | 88% Sell | ||
| Previous Opinion | 8% Sell | 56% Sell | 88% Sell | ||
| Last Month's Opinion | 32% Buy | 88% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.42% since 04/21/25 | -0.98% since 04/21/25 | +8.79% since 04/21/25 | ||
| Low | 36.08 on 04/22/25 | 46.93 on 04/24/25 | 565.14 on 04/22/25 | ||
| High | 38.20 on 04/28/25 | 50.06 on 04/22/25 | 614.83 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | -1.76% since 03/28/25 | -19.26% since 03/28/25 | -4.16% since 03/28/25 | ||
| Low | 32.38 on 04/09/25 | 46.93 on 04/24/25 | 525.99 on 04/09/25 | ||
| High | 39.17 on 04/03/25 | 61.64 on 03/31/25 | 641.24 on 04/01/25 | ||
| 3-Month | |||||
| %Chg | +8.43% since 01/28/25 | -17.53% since 01/28/25 | -11.00% since 01/28/25 | ||
| Low | 32.38 on 04/09/25 | 46.93 on 04/24/25 | 525.99 on 04/09/25 | ||
| High | 40.81 on 03/10/25 | 63.33 on 03/11/25 | 748.29 on 03/10/25 | ||
| 6-Month | |||||
| %Chg | +0.48% since 10/28/24 | -7.94% since 10/28/24 | -34.22% since 10/28/24 | ||
| Low | 31.72 on 01/14/25 | 46.93 on 04/24/25 | 525.99 on 04/09/25 | ||
| High | 40.81 on 03/10/25 | 63.33 on 03/11/25 | 935.86 on 10/30/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 75,369,856 | 112,522,392 | 62,692,416 | ||
| Shares Outstanding, K | 2,063,232 | 2,034,763 | 109,325 | ||
| Annual Sales | 40,095,390,000 | 48,300,000,000 | 14,202,000,000 | ||
| Annual Net Income | 3,290,590,000 | -8,948,000,000 | 4,412,600,000 | ||
| Last Quarter Sales | 10,387,570,000 | 12,342,000,000 | 3,789,200,000 | ||
| Last Quarter Net Income | 559,150,000 | 72,000,000 | 917,700,000 | ||
| 60-Month Beta | 0.56 | 0.41 | 0.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.59 on 02/05/25 | 1.80 on 04/24/25 | 12.07 on 02/04/25 | ||
| Latest Earnings Date | 04/30/25 | 04/24/25 | 04/29/25 | ||
| Most Recent Dividend | 0.400 on 02/21/25 | 0.620 on 04/04/25 | 0.880 on 02/20/25 | ||
| Next Ex-Dividends Date | 02/21/25 | 04/04/25 | 02/20/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 9.26 | 6.53 | 15.18 | ||